Molecular Alterations in Atypical Adenomatous Hyperplasia Occurring in Benign and Cancer-bearing Lungs
暂无分享,去创建一个
[1] E. Ruffini,et al. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[2] K. Kerr,et al. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma , 2004, The Journal of pathology.
[3] S. Dacic,et al. Molecular Pathogenesis of Pulmonary Carcinosarcoma as Determined by Microdissection-Based Allelotyping , 2002, The American journal of surgical pathology.
[4] Y. Nishiwaki,et al. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. , 2001, The American journal of pathology.
[5] A. Ochiai,et al. Atypical adenomatous hyperplasia of the lung in autopsy cases. , 2001, Lung cancer.
[6] H. Popper,et al. Atypical Adenomatous Hyperplasia of the Lung: A Probable Forerunner in the Development of Adenocarcinoma of the Lung , 2001, Modern Pathology.
[7] Y. Takeshima,et al. Correlation between genetic alterations and histopathological subtypes in bronchiolo‐alveolar carcinoma and atypical adenomatous hyperplasia of the lung , 2000, Pathology international.
[8] K. Kerr,et al. The association between atypical adenomatous hyperplasia and primary lung cancer , 2000, British Journal of Cancer.
[9] A. Ochiai,et al. High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms. , 2000, Lung cancer.
[10] Takaaki Ito,et al. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. , 1999, American journal of clinical pathology.
[11] K. Hiroshima,et al. p53 Mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma , 1999, Cancer.
[12] C. Croce,et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. , 1998, Cancer research.
[13] F. Tezuka,et al. Comparative ultrastructural study of atypical adenomatous hyperplasia and adenocarcinoma of the human lung. , 1998, Ultrastructural pathology.
[14] R. Hruban,et al. p53 alterations in atypical alveolar hyperplasia of the human lung. , 1998, Human pathology.
[15] M. Sagawa,et al. K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer. , 1998, British Journal of Cancer.
[16] J. Samet,et al. Molecular damage in the bronchial epithelium of current and former smokers. , 1997, Journal of the National Cancer Institute.
[17] V. Roggli,et al. Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[18] R. Hruban,et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. , 1996, Cancer research.
[19] Y. Inayama,et al. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. , 1996, The American journal of surgical pathology.
[20] Y. Inayama,et al. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. , 1995, The American journal of pathology.
[21] K. Kerr,et al. Atypical alveolar hyperplasia: Relationship with pulmonary adenocarcinoma, p53, and c‐erbB‐2 expression , 1994, The Journal of pathology.
[22] K. Kerr,et al. Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases. , 1992, Thorax.
[23] Roberta R. Miller. Bronchioloalveolar Cell Adenomas , 1990, The American journal of surgical pathology.
[24] R. Tsuchiya,et al. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[25] N. Müller,et al. Glandular neoplasia of the lung. A proposed analogy to colonic tumors , 1988, Cancer.
[26] Y. Ishikawa,et al. High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs , 2005, Journal of Cancer Research and Clinical Oncology.
[27] J. Luketich,et al. Widespread Molecular Alterations Present in Stage I Non-Small Cell Lung Carcinoma Fail to Predict Tumor Recurrence , 2003, Modern Pathology.
[28] Y. Pekarsky,et al. Role of FHIT in human cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Y. Nishiwaki,et al. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. , 1997, Cancer.
[30] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.